Correlation Between Dosimetric Parameters and Local Control in Definitive Radiotherapy for Head and Neck Cancers

Overview

Journal In Vivo

Specialty Oncology

Date 2024 Feb 28

PMID 38418123

Authors

Mikiko Yamashita

Shingo Ohira

Hiroaki Tanabe

Masaki Kokubo

Masahiko Koizumi

Affiliations

Soon will be listed here.

Abstract

Background/aim: Radiotherapy (RT) outcomes are generally reported based on stage, patient background, and concomitant chemotherapy. This study aimed to investigate the effects of the prescribed dose to gross tumor volume (GTV) and the calculation algorithm on local control in definitive RT for head and neck (H&N) cancers using follow-up images after RT.

Patients And Methods: This study included 154 patients with H&N cancers treated by Volumetric Modulated Arc Therapy at the Kobe City Medical Center General Hospital. Patients were classified into those receiving definitive RT (70 Gy of irradiation) and those not receiving it. Follow-up images were used to categorize the patients into the responders and non-responders groups. In the non-responders group, follow-up images were imported into the treatment planning system, and the contours of the residual or recurrent areas (local failure) were extracted and fused with computed tomography-simulated images for treatment planning. Dose evaluation parameters included maximum dose, dose administered to 1% of the volume, dose administered to 50% of the volume, dose administered to 99% of the volume (D), and minimum dose (D) administered to the GTV. The doses to the GTV were compared between responders and non-responders.

Results: D exhibited significant differences between local failure and responders and between local failure and non-responders. D showed significant differences between responders and non-responders and between responders and local failure.

Conclusion: This study emphasizes the importance of verifying dose distribution in all slices of treatment planning, highlighting the need for precise assessment of the dose to the GTV in head and neck cancers.

Citing Articles

A New Approach to Highly Conformal Hippocampal-sparing Whole-brain Radiotherapy: A Feasibility Study.

Ziemann C, Cremers F, MacPherson M, Rades D, Loser A In Vivo. 2025; 39(2):834-843.

PMID: 40010946 PMC: 11884443. DOI: 10.21873/invivo.13886.

References

Morgan H, Sher D . Adaptive radiotherapy for head and neck cancer. Cancers Head Neck. 2020; 5:1. PMC: 6953291. DOI: 10.1186/s41199-019-0046-z. View

Han T, Mourtada F, Kisling K, Mikell J, Followill D, Howell R . Experimental validation of deterministic Acuros XB algorithm for IMRT and VMAT dose calculations with the Radiological Physics Center's head and neck phantom. Med Phys. 2012; 39(4):2193-202. PMC: 3337663. DOI: 10.1118/1.3692180. View

Vanetti E, Clivio A, Nicolini G, Fogliata A, Ghosh-Laskar S, Agarwal J . Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol. 2009; 92(1):111-7. DOI: 10.1016/j.radonc.2008.12.008. View

Johansen S, Norman M, Dale E, Amdal C, Furre T, Malinen E . Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer. Radiat Oncol. 2017; 12(1):87. PMC: 5444101. DOI: 10.1186/s13014-017-0829-5. View

Vlacich G, Stavas M, Pendyala P, Chen S, Shyr Y, Cmelak A . A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer. Radiat Oncol. 2017; 12(1):13. PMC: 5237132. DOI: 10.1186/s13014-016-0756-x. View

Price R, Koren S, Hossain M, Veltchev I, Galloway T, Flanagan P . SU-E-T-554: PTV to Skin Proximity for Head and Neck IMRT Treatment Planning. Med Phys. 2017; 39(6Part18):3833. DOI: 10.1118/1.4735643. View

Bassi S, Tyner E . 6X acuros algorithm validation in the presence of inhomogeneities for VMAT treatment planning. Rep Pract Oncol Radiother. 2020; 25(4):539-547. PMC: 7256059. DOI: 10.1016/j.rpor.2020.03.018. View

Lloyd S, Ansbacher W . Evaluation of an analytic linear Boltzmann transport equation solver for high-density inhomogeneities. Med Phys. 2013; 40(1):011707. DOI: 10.1118/1.4769419. View

Reft C, Alecu R, Das I, Gerbi B, Keall P, Lief E . Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63. Med Phys. 2003; 30(6):1162-82. DOI: 10.1118/1.1565113. View

10.

Sheikhbahaei S, Taghipour M, Ahmad R, Fakhry C, Kiess A, Chung C . Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2015; 205(3):629-39. DOI: 10.2214/AJR.14.14166. View

11.

Tanaka Y, Monzen H, Matsumoto K, Inomata S, Fuse T . Dose distribution comparison in volumetric-modulated arc therapy plans for head and neck cancers with and without an external body contour extended technique. Rep Pract Oncol Radiother. 2019; 24(6):576-584. PMC: 6838917. DOI: 10.1016/j.rpor.2019.09.003. View

12.

Chao K, Ozyigit G, Tran B, Cengiz M, Dempsey J, Low D . Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003; 55(2):312-21. DOI: 10.1016/s0360-3016(02)03940-8. View

13.

Sasaki M, Ikushima H, Nakaguchi Y, Kishi T, Kimura M, Bandou R . [A comparison of four commercial radiation treatment planning systems for prostate intensity modulated radiation therapy]. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2013; 69(7):761-72. DOI: 10.6009/jjrt.2013_jsrt_69.7.761. View

14.

Srivastava R, Basta K, De Gersem W, De Wagter C . A comparative analysis of Acuros XB and the analytical anisotropic algorithm for volumetric modulation arc therapy. Rep Pract Oncol Radiother. 2021; 26(3):481-488. PMC: 8281916. DOI: 10.5603/RPOR.a2021.0050. View

15.

Baba M, Singh B, Wani S . Skin Sparing in Intensity-Modulated Radiation Therapy of Nasopharyngeal Carcinoma. J Med Phys. 2023; 47(3):243-249. PMC: 9847000. DOI: 10.4103/jmp.jmp_27_22. View

16.

Chen Y, Chan A, Le Q, Blanchard P, Sun Y, Ma J . Nasopharyngeal carcinoma. Lancet. 2019; 394(10192):64-80. DOI: 10.1016/S0140-6736(19)30956-0. View

17.

Kan M, Leung L, Yu P . Dosimetric impact of using the Acuros XB algorithm for intensity modulated radiation therapy and RapidArc planning in nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys. 2012; 85(1):e73-80. DOI: 10.1016/j.ijrobp.2012.08.031. View

18.

Brodin N, Tome W . Revisiting the dose constraints for head and neck OARs in the current era of IMRT. Oral Oncol. 2018; 86:8-18. PMC: 6481934. DOI: 10.1016/j.oraloncology.2018.08.018. View

19.

Ciardo D, Alterio D, Jereczek-Fossa B, Riboldi M, Zerini D, Santoro L . Set-up errors in head and neck cancer patients treated with intensity modulated radiation therapy: Quantitative comparison between three-dimensional cone-beam CT and two-dimensional kilovoltage images. Phys Med. 2015; 31(8):1015-1021. DOI: 10.1016/j.ejmp.2015.08.004. View

20.

Oksuz D, Prestwich R, Carey B, Wilson S, Senocak M, Choudhury A . Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy. Radiat Oncol. 2011; 6:54. PMC: 3127781. DOI: 10.1186/1748-717X-6-54. View